Infinity Pharmaceuticals | INFI - Ebitda


Infinity Pharmaceuticals reported $-10.01M in EBITDA for its fiscal quarter ending in June of 2023.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 1.96B 1.27B Jun/2025
Eisai JPY 30.1B 6.62B Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025
Incyte USD 414.5M 92.42M Dec/2025
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
J&J USD 9.52B 389M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 37.7M 25.41M Jun/2025